Iopidine

Apraclonidine Hydrochloride, the active ingredient in Iopidine, is a Alpha-2 adrenergic agonist presented as a 0.5% w/v ophthalmic solution for topical ocular use. It treats ocular hypertension, open‑angle glaucoma and helps lower intra‑ocular pressure after ocular surgery. GNH USA supplies Iopidine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iopidine (apraclonidine) is used in the management of ocular pressure‑related conditions.

- Ocular hypertension: reduces intra‑ocular pressure to prevent progression to glaucoma. - Open‑angle glaucoma: lowers intra‑ocular pressure to slow optic nerve damage. - Post‑operative ocular surgery: decreases intra‑ocular pressure to aid healing.

Apraclonidine may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation: transient burning or stinging sensation. - Redness: conjunctival hyperemia. - Blurred vision: temporary visual disturbance. - Dry eye: decreased tear production.

Serious or Rare Side Effects: - Allergic reaction: eyelid edema, rash. - Severe ocular inflammation: uveitis. - Systemic hypotension: dizziness or fainting. - Cardiac arrhythmia: irregular heartbeat.

When using Iopidine, consider the following precautions. - Pregnancy: Category B – use only if clearly needed. - Breastfeeding: Caution – may be excreted in milk. - Contact lens wearers: Remove lenses before instillation; wait before reinserting. - Concomitant ocular surgery: Monitor intra‑ocular pressure closely. - Allergic history: Assess for hypersensitivity to apraclonidine. - Store at room temperature: keep in original container, protect from light and moisture.

Apraclonidine can interact with other medications.

Major Interactions (Avoid): - Other alpha‑2 agonists: additive ocular hypotensive effect may cause excessive pressure reduction. - Systemic antihypertensives: may enhance systemic hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: combined effect on intra‑ocular pressure. - Carbonic anhydrase inhibitors: additive pressure‑lowering effect. - Tricyclic antidepressants: may reduce efficacy of apraclonidine.